EMA Archives - Express Pharma

Nezglyal remains promising therapy despite EMA’s market authorisation refusal: GlobalData

US FDA approves GSK’s Arexvy, world’s first RSV vaccine for older adults

EMA seeks to issue guidance on liver damage from Novartis’s gene therapy

Sanofi and AstraZeneca win EU approval for prevention of infant RSV

EMA recommends Moderna’s updated Omicron-tailored vaccine

Pfizer announces positive results from phase-III study in 20-valent Pneumococcal Conjugate Vaccine in infants in EU

EMA validates Gilead’s Marketing Authorisation Application for Lenacapavir

EMA recommends marketing authorisation for Scemblix by Novartis

EU drugs watchdog begins review of Moderna’s variant COVID vaccine

Pfizer and BioNTech submit application for US EUA for COVID vaccine booster dose in kids aged five to 11 years